🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Neutropenic fever is a life threatening condition that is not rare in patie...
Status
Unknown
Location
Tel-Aviv Sourasky Medicak center / BMT Unit
Start Date
2015-06
Trial ID
NCT02463747
Treatments Being Tested
The purpose of the study is to find out if high dose antibiotic (meropenem,...
Status
Completed
Location
Multiple Locations
Start Date
2002-07
Trial ID
NCT00050401
The primary objective of this study is to demonstrate a low rate of emergen...
Status
Terminated
Location
InClin, Inc.
Start Date
2010-09
Trial ID
NCT01570192
Treatments Being Tested
A prospective, open-label study investigated the pharmacokinetic profile of...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT02506686
Treatments Being Tested
The purpose of this study is to demonstrate the non-inferiority of meropene...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT00619710
Treatments Being Tested
The aim of this work is to evaluate the efficacy associated with Meropenem(...
Status
Active Not Recruiting
Location
Ain Shams University Hospitals
Start Date
2024-01-01
Trial ID
NCT07096310
Treatments Being Tested
The goal of this clinical research study is to learn if the study drug ceft...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-05-16
Trial ID
NCT03485950
Treatments Being Tested
The objective of this study is to describe the pharmacokinetics of tigecycl...
Status
Completed
Location
II Department of Anesthesia and Intensive Care, Medical University of Lublin
Start Date
2017-01-15
Trial ID
NCT03034174
This study is non-inferiority trial design. This study aimed to investigate...
Status
Recruiting
Location
Children's Hospital of Fudan University
Start Date
2023-07-01
Trial ID
NCT05925309
This phase II trial studies the effect of imipenem-relebactam in treating p...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-09-14
Trial ID
NCT04983901